Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1110-1117

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prestigiacomo, C. J.
Right arrow Articles by Feuerstein, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prestigiacomo, C. J.
Right arrow Articles by Feuerstein, G.
Related Collections
Right arrow Animal models of human disease
Right arrow Embolic stroke
Right arrow Thrombolysis
Right arrow Other Stroke Treatment - Medical

(Stroke. 1999;30:1110-1117.)
© 1999 American Heart Association, Inc.


Original Contributions

CD18-Mediated Neutrophil Recruitment Contributes to the Pathogenesis of Reperfused but Not Nonreperfused Stroke

Charles J. Prestigiacomo, MD; Samuel C. Kim, MD; E. Sander Connolly, Jr, MD; Hui Liao, MD; Shi-Fang Yan, MD David J. Pinsky, MD

From Columbia University, College of Physicians and Surgeons, New York, NY.

Correspondence to Dr David J. Pinsky, Columbia University, Department of Medicine, PH 10 Stem, 630 W 168th St, New York, NY 10032. E-mail djp5{at}columbia.edu

Background and Purpose—Neutrophil (PMN) recruitment mediated by increased expression of intercellular adhesion molecule-1 expression (ICAM-1, CD54) in the cerebral microvasculature contributes to the pathogenesis of tissue injury in stroke. However, studies using blocking antibodies against the common ß2-integrin subunit on the PMN, the counterligand for ICAM-1 (CD18), have demonstrated equivocal efficacy. The current study tested the hypothesis that mice deficient in CD18 would be protected in the setting of reperfused but not nonreperfused stroke.

Methods—Two groups of mice were studied, those whose PMNs could express CD18 (CD18 +/+) and those mice hypomorphic for the CD-18 gene (CD18 -/-). PMNs obtained from CD18 -/- or CD18 +/+ mice were fluorescently labeled and tested for binding to murine brain endothelial monolayers. Using a murine model of focal cerebral ischemia in which an occluding suture placed in the middle cerebral artery (MCA) is removed after 45 minutes (transient ischemia, reperfused stroke) or left in place (permanent ischemia, nonreperfused stroke), cerebral infarct volumes (% ipsilateral hemisphere by TTC staining), cerebral blood flow (CBF, % contralateral hemisphere by laser-Doppler flowmetry), and survival (%) were examined 24 hours after the initial ischemic event. Adoptive transfer studies used 111In-labeled PMNs (from either CD18 +/+ or CD18 -/- mice) to examine the relative accumulation of PMNs in the ischemic region.

Results—PMNs obtained from CD18 -/- mice exhibit reduced adhesivity (compared with CD18 +/+ PMNs) for both quiescent and cytokine-activated endothelial monolayers. CD18 -/- mice (n=14) subjected to transient focal cerebral ischemia demonstrated a 53% decrease in infarct volumes versus CD18 +/+ mice (n=26, P<0.05), improved penumbral CBF at 24 hours (1.8-fold, P=0.02), and a 3.7-fold decrease in mortality (P=0.02). However, when CD18 -/- mice (n=12) were subjected to permanent focal cerebral ischemia, no differences were noted in infarct volume, mortality, or CBF versus similarly treated CD18 +/+ mice (n=10). There was a greater accumulation of CD18 +/+ PMNs in the ischemic zone of CD18 +/+ animals than CD18 -/- animals subjected to reperfused stroke (82% increase, P=0.02), although there was no difference between groups when subjected to permanent MCA occlusion.

Conclusions—Deficiency for the CD18 gene confers cerebral protection in a murine model of reperfused stroke, but this benefit does not extend to CD18-deficient animals subjected to permanent MCA occlusion. These data suggest that anti-PMN strategies should be targeted to reperfused stroke and may perhaps be used in conjunction with thrombolytic therapy that establishes reperfusion.

Editorial Comment

Giora Feuerstein, MD, Guest Editor

Cardiovascular Disease Research, DuPont Pharmaceuticals Company, Wilmington, Delaware




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. Neumann, S. Sauerzweig, R. Ronicke, F. Gunzer, K. Dinkel, O. Ullrich, M. Gunzer, and K. G. Reymann
Microglia Cells Protect Neurons by Direct Engulfment of Invading Neutrophil Granulocytes: A New Mechanism of CNS Immune Privilege
J. Neurosci., June 4, 2008; 28(23): 5965 - 5975.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Terao, G. Yilmaz, K. Y. Stokes, M. Ishikawa, T. Kawase, and D. N. Granger
Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice
Stroke, March 1, 2008; 39(3): 943 - 950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Gidday, Y. G. Gasche, J.-C. Copin, A. R. Shah, R. S. Perez, S. D. Shapiro, P. H. Chan, and T. S. Park
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H558 - H568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Rane, D. Gozal, W. Butt, E. Gozal, W. M. Pierce Jr, S. Z. Guo, R. Wu, A. D. Goldbart, V. Thongboonkerd, K. R. McLeish, et al.
{gamma}-Amino Butyric Acid Type B Receptors Stimulate Neutrophil Chemotaxis during Ischemia-Reperfusion
J. Immunol., June 1, 2005; 174(11): 7242 - 7249.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger
CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion
Circulation, April 5, 2005; 111(13): 1690 - 1696.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Nicholls, G. J. Dusting, B. Cutri, S. Bao, G. R. Drummond, K.-A. Rye, and P. J. Barter
Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits
Circulation, March 29, 2005; 111(12): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. V. Arumugam, J. W. Salter, J. H. Chidlow, C. M. Ballantyne, C. G. Kevil, and D. N. Granger
Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2555 - H2560.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. E. Sughrue, E. S. Connolly Jr, M. Krams, K. R. Lees, W. Hacke, A. P. Grieve, J.-M. Orgogozo, and G. A. Ford
Effectively Bridging the Preclinical/Clinical Gap: The Results of the ASTIN Trial * Response
Stroke, April 1, 2004; 35(4): e81 - e82.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Dinkel, F. S. Dhabhar, and R. M. Sapolsky
Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures
PNAS, January 6, 2004; 101(1): 331 - 336.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Cherian, G. J. Hankey, J. W. Eikelboom, J. Thom, R. I. Baker, A. McQuillan, J. Staton, and Q. Yi
Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes
Stroke, September 1, 2003; 34(9): 2132 - 2137.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, M. Krams, and M. Chopp
Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of Stroke
Stroke, July 1, 2003; 34(7): 1790 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Mocco, T. Choudhri, J. Huang, E. Harfeldt, L. Efros, C. Klingbeil, V. Vexler, W. Hall, Y. Zhang, W. Mack, et al.
HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke
Circ. Res., November 15, 2002; 91(10): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.J.M. Frijns and L.J. Kappelle
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Stroke, August 1, 2002; 33(8): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Kubes, D. Payne, and R. C. Woodman
Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation
Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G139 - G147.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Campanella, C. Sciorati, G. Tarozzo, and M. Beltramo
Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain
Stroke, February 1, 2002; 33(2): 586 - 592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Huang, D. B. Agus, C. J. Winfree, S. Kiss, W. J. Mack, R. A. McTaggart, T. F. Choudhri, L. J Kim, J Mocco, D. J. Pinsky, et al.
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
PNAS, September 25, 2001; 98(20): 11720 - 11724.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Huang, T. F. Choudhri, C. J. Winfree, R. A. McTaggart, S. Kiss, J. Mocco, L. J. Kim, T. S. Protopsaltis, Y. Zhang, D. J. Pinsky, et al.
Postischemic Cerebrovascular E-Selectin Expression Mediates Tissue Injury in Murine Stroke Editorial Comment
Stroke, December 1, 2000; 31(12): 3047 - 3053.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. D. Ginsberg
On Ischemic Brain Injury in Genetically Altered Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2581 - 2583.
[Full Text] [PDF]


Home page
ScienceHome page
J. Huang, L. J. Kim, R. Mealey, H. C. Marsh Jr., Y. Zhang, A. J. Tenner, E. S. Connolly Jr., and D. J. Pinsky
Neuronal Protection in Stroke by an sLex-Glycosylated Complement Inhibitory Protein
Science, July 23, 1999; 285(5427): 595 - 599.
[Abstract] [Full Text]